Skip to main content
An official website of the United States government
Grant Details

Grant Number: 5R01CA228357-05 Interpret this number
Primary Investigator: Palmer, Julie
Organization: Boston University Medical Campus
Project Title: Improving Breast Cancer Risk Prediction for African American Women: Consideration of Estrogen Receptor Subtype-Specific Risk Factors
Fiscal Year: 2023


PROJECT SUMMARY Improved breast cancer risk prediction is of critical importance for African American (AA) women in view of their younger age at diagnosis, higher incidence of the most aggressive subtypes (e.g., estrogen receptor negative (ER-) breast cancer), and 40% higher breast cancer mortality compared with white women. Several models, including the well-known Breast Cancer Risk Assessment Tool (Gail model), have been developed, largely in white populations, to assess a woman’s absolute risk of breast cancer; they have been used to identify high-risk women for supplemental screening, preventive treatment, and enrollment in chemoprevention trials. Only two prediction models have been developed specifically for AA women and both have low discriminatory accuracy. Recent research by our group and others indicates distinct etiologic pathways for breast cancer subtypes defined by ER status in that associations with parity, breastfeeding, postmenopausal hormone use, and body size differ by ER status. For example, high parity is associated with reduced risk of ER+ cancer and with increased risk of ER- cancer. The relatively poor discriminatory accuracy of breast cancer risk prediction models in AA women may reflect the failure to properly consider tumor subtypes. This is a lesser concern in other ethnic groups in which the vast majority of cases are ER+, whereas up to a third of AA cases are ER-. In a novel approach, we will first estimate ER specific relative risk estimates from analyses of pooled data from AA women in three population-based case-control studies, including 1382 ER- and 2275 ER+ breast cancer cases, as well as 3341 controls. We will then use those estimates, together with SEER age-incidence rates for ER+ and ER- breast cancer in AA women to estimate baseline age-specific hazard rates for ER+ and ER- cancer. Finally, we will combine relative risks and baseline hazards, taking into account competing risks, to estimate the probability of developing the first of either ER+ or ER- breast cancer over a pre-specified time interval given a woman’s age and risk factors. Performance of the ER specific models and the overall tool for predicting any breast cancer will be tested in prospective cohort data from the Black Women’s Health Study (BWHS), based on occurrence of 703 ER- and 1502 ER+ cases. Existing risk prediction models for AA women will also be applied to the prospective BWHS data in order to compare their performance with performance of our new tool. Although genome-wide genotyping is not yet a part of each patient’s medical records, to set the stage for such genotyping in the future, in a second aim we will add SNPs associated with breast cancer subtypes identified in GWAS and fine-mapping of AA women to the models and evaluate changes in performance. Improved breast cancer risk prediction models in AA women will lead to earlier detection and treatment of high risk women, and thereby to reduced breast cancer mortality.


Validating a model for predicting breast cancer and nonbreast cancer death in women aged 55 years and older.
Authors: Wolfson E.A. , Schonberg M.A. , Eliassen A.H. , Bertrand K.A. , Shvetsov Y.B. , Rosner B.A. , Palmer J.R. , LaCroix A.Z. , Chlebowski R.T. , Nelson R.A. , et al. .
Source: Journal of the National Cancer Institute, 2024-01-10; 116(1), p. 81-96.
PMID: 37676833
Related Citations

Addition of polygenic risk score to a risk calculator for prediction of breast cancer in US Black women.
Authors: Zirpoli G.R. , Pfeiffer R.M. , Bertrand K.A. , Huo D. , Lunetta K.L. , Palmer J.R. .
Source: Breast cancer research : BCR, 2024-01-02; 26(1), p. 2.
EPub date: 2024-01-02.
PMID: 38167144
Related Citations

A model for predicting both breast cancer risk and non-breast cancer death among women > 55 years old.
Authors: Schonberg M.A. , Wolfson E.A. , Eliassen A.H. , Bertrand K.A. , Shvetsov Y.B. , Rosner B.A. , Palmer J.R. , Ngo L.H. .
Source: Breast cancer research : BCR, 2023-01-24; 25(1), p. 8.
EPub date: 2023-01-24.
PMID: 36694222
Related Citations

Polygenic risk scores for prediction of breast cancer risk in women of African ancestry: a cross-ancestry approach.
Authors: Gao G. , Zhao F. , Ahearn T.U. , Lunetta K.L. , Troester M.A. , Du Z. , Ogundiran T.O. , Ojengbede O. , Blot W. , Nathanson K.L. , et al. .
Source: Human molecular genetics, 2022-09-10; 31(18), p. 3133-3143.
PMID: 35554533
Related Citations

A Validated Risk Prediction Model for Breast Cancer in US Black Women.
Authors: Palmer J.R. , Zirpoli G. , Bertrand K.A. , Battaglia T. , Bernstein L. , Ambrosone C.B. , Bandera E.V. , Troester M.A. , Rosenberg L. , Pfeiffer R.M. , et al. .
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021-12-01; 39(34), p. 3866-3877.
EPub date: 2021-10-08.
PMID: 34623926
Related Citations

Evaluating Polygenic Risk Scores for Breast Cancer in Women of African Ancestry.
Authors: Du Z. , Gao G. , Adedokun B. , Ahearn T. , Lunetta K.L. , Zirpoli G. , Troester M.A. , Ruiz-Narváez E.A. , Haddad S.A. , PalChoudhury P. , et al. .
Source: Journal of the National Cancer Institute, 2021-09-04; 113(9), p. 1168-1176.
PMID: 33769540
Related Citations

Cancer health disparities in racial/ethnic minorities in the United States.
Authors: Zavala V.A. , Bracci P.M. , Carethers J.M. , Carvajal-Carmona L. , Coggins N.B. , Cruz-Correa M.R. , Davis M. , de Smith A.J. , Dutil J. , Figueiredo J.C. , et al. .
Source: British journal of cancer, 2021 Jan; 124(2), p. 315-332.
EPub date: 2020-09-09.
PMID: 32901135
Related Citations

Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women.
Authors: Palmer J.R. , Polley E.C. , Hu C. , John E.M. , Haiman C. , Hart S.N. , Gaudet M. , Pal T. , Anton-Culver H. , Trentham-Dietz A. , et al. .
Source: Journal of the National Cancer Institute, 2020-12-14; 112(12), p. 1213-1221.
PMID: 32427313
Related Citations

Polygenic Risk Scores for Breast Cancer Risk Prediction: Lessons Learned and Future Opportunities.
Authors: Palmer J.R. .
Source: Journal of the National Cancer Institute, 2020-06-01; 112(6), p. 555-556.
PMID: 31553456
Related Citations

Back to Top